ArticleFrontiers in oncology2020

Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report.

Michele Guida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.